Qube Research & Technologies (QRT)
NGM

Qube Research & Technologies (QRT)’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio NGM Stock Details NGM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-384
Closed -$330 – 4984
2023
Q4 		$330 Sell
384
-16,209
-98% -$14.2K ﹤0.01% 3950
2023
Q3 		$17.8K Sell
16,593
-45,024
-73% -$93.2K ﹤0.01% 3178
2023
Q2 		$160K Buy
61,617
+28,779
+88% +$103K ﹤0.01% 1844
2023
Q1 		$134K Sell
32,838
-4,368
-12% -$20.2K ﹤0.01% 2051
2022
Q4 		$187K Buy
+37,206
New +$233K ﹤0.01% 1844
2020
Q3 		– Sell
-39,472
Closed -$779K – 2196
2020
Q2 		$779K Buy
+39,472
New +$754K 0.01% 949

Other funds holding NGM

CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SG
StepStone Group La Jolla, California $207M AUM 12.33% 1-Year Est. Return
EC
Euclidean Capital New York $392M AUM 31.85% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
TC
Trium Capital London, United Kingdom $163M AUM 45.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $1.7B AUM 340.85% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Qube Research & Technologies (QRT)'s NGM Position: Q1 2024 in Review

Qube Research & Technologies (QRT) sold out of NGM Biopharmaceuticals, Inc. Common Stock (NGM) in Q1 2024, closing a stake of 384 shares — an estimated $330 sold.

Qube Research & Technologies (QRT) first reported a position in NGM in Q2 2020 and held it in 6 quarters. The position peaked at $779K in Q2 2020. 75 funds tracked by Wall St. Rank hold NGM as of Q1 2024.

  • Qube Research & Technologies (QRT) reported no remaining NGM Biopharmaceuticals, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Qube Research & Technologies (QRT) sold 384 NGM Biopharmaceuticals, Inc. Common Stock shares in Q1 2024, an estimated $330.
  • Qube Research & Technologies (QRT) first reported a position in NGM Biopharmaceuticals, Inc. Common Stock in Q2 2020 and held it in 6 quarters.
  • Qube Research & Technologies (QRT)'s NGM Biopharmaceuticals, Inc. Common Stock position peaked at $779K in Q2 2020.
  • 75 funds tracked by Wall St. Rank held NGM Biopharmaceuticals, Inc. Common Stock as of Q1 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2024, filed 14 May 2024.